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Abstract
This study was conducted to develop a novel algorithm for determining the origin of tumors
by combining analysis of cluster patterns with immunocytochemistry (ICC) for markers in
cells from fine-needle aspirates of ascites. We used LBC, based on SurePathTM (BD Diag-
nostics) technology, to screen 96 peritoneal fluid samples from patients with known malig-
nancies and from 10 control patients with cirrhosis. Following dual ICC staining for
cytokeratin 7 (CK7) and paired box gene 8 (PAX8), we developed an algorithm using immu-
noreactivity and three-dimensional (3D) cluster patterns to correlate staining and 3D cluster
patterns with common primary origins that included stomach, ovarian, pancreatobiliary tract,
colon, lung, and breast cancers. With the application of an automatic digitalized image ana-
lyzer, competence performance was analyzed using receiver operating characteristics
(ROC) curve analysis. CK7 and PAX8 staining and 3D cluster patterns were used to differ-
entiate primary origins. Samples from patients with stomach cancer were no 3D cluster
/CK7+/PAX8- with area under the curve (AUC) of 0.8699 in ROC curve analysis. Samples
from ovarian cancer patients were large 3D cluster/CK7+/PAX8+ with AUC of 0.9812. Sam-
ples from pancreatobiliary tract cancer patients were small 3D cluster/CK7+/PAX8- with
AUC of 0.8772. The remaining cancer samples, including breast, lung and colon cancer
samples, had similar patterns of large 3D clusters/CK7+/PAX8- with AUC of 0.882, espe-
cially for lung cancer. SurePathTM technology, using 3D cluster patterns and dual ICC for
CK7 and PAX8 in peritoneal fluid samples, can provide important information for determin-
ing specific primary origins in cases of unknown primary carcinoma.
Introduction
Ascites, excess peritoneal fluid, is common in various diseases, including serous fluids in liver
cirrhosis and turbid exudative fluids in various inflammation settings, including malignant
tumors in visceral and pelvic organs. The primary origin of malignant ascites can be any site
beyond the peritoneum; the most common origins in our cohort were ovary, stomach, and
pancreaticobiliary tract. With optimal interpretation, fluid cytology could meet clinical
demands by alleviating diagnostic and therapeutic conundra.[1] However, the interpretation
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of fluid cytology in third spaces remains a challenging field. The spectrum is remarkably wide
with regard to benign or malignant diagnoses, even between tumorous or non-tumorous diag-
noses, making clear diagnoses difficult. Furthermore, determination of the type of primary
tumor, even in the case of malignant conditions, may not be possible using cytology alone.
Many situations encounter equivocal or obscure tumor origins based on clinical or radiologi-
cal information.
With the introduction of liquid-based cytology (LBC), ancillary studies, including molecu-
lar analysis and immunocytochemistry (ICC), could be utilized to alleviate diagnostic conun-
dra.[2–8] However, the wide application of LBC is less practical. The main reason why LBC is
less easily applied resides in the practical difficulty of the involved ICC, which is relatively diffi-
cult compared to traditional immunohistochemistry. Another difficulty is the lack of well-doc-
umented biomarkers, except for those involved in HPV testing. Cytokeratin 7 (CK7) and
paired box gene 8 (PAX8) are currently the best markers for determining primary origin in
ovarian carcinoma, stomach cancer, and pancreatobiliary tract cancer.[9,10]
Here, we aimed to develop a novel algorithm for determining the origin of tumors by com-
bining analysis of cluster patterns with ICC for markers in cells from fine-needle aspirates of
ascites.
Materials and methods
Case and control sample selection
A total of 247 fluid samples were collected via aspiration from peritoneal ascites and stored in
a frozen state. Within 6 months of collection, samples were screened and qualified for further
evaluation. Cases with low levels of fluid, cell paucity, or ambiguous primary tumors were
excluded. To confirm the primary origin of malignant peritoneal fluids, we compared cytologi-
cal specimens with paired tissue specimens. When no available tissue specimens, we referred
to clinical information and performed ICC for cancer-specific biomarkers.
Finally, 96 malignant peritoneal fluids (33 stomach cancer, 34 ovary cancer, 13 pancreatobi-
liart tract cancer, 9 lung cancer, 4 colon cancer and 3 breast cancer patients) were selected.
And ten peritoneal fluid samples aspirated from cirrhosis patients were selected as a control
group. The need for consent was waived and this study was approved by the Institutional
Review Board of Severance Hospital (4-2016-0225).
Preparation of unstained liquid-based cytology slides
For ICC, unstained LBC slides were prepared using the SurePathTM method (BD TotalysTM
SlidePrep System, BD Diagnostics, Burlington, NC). Briefly, unstained LBC slides were pre-
pared according to the manufacturer’s protocol. CytoRich Red (CRR) fixative samples were
centrifuged at 3240 rpm for 5 minutes. Supernatant fluids were removed and pellets were vor-
texed to homogenize the sample. When no visible or small pellets were identified, representa-
tive samples (1 to 5 drops) were transferred to 5 mL buffered distilled deionized water.
Following centrifugation for 5 min at 3240 rpm, supernatant fluids were decanted and pellets
were vortexed for 15 seconds to homogenize samples. The samples were transferred onto the
BD TotalysTM SlidePrep system for processing. BD SurePathTM PreCoat slides were placed on
the slide racks in the same position as the tubes. Following execution of the NON-GYN pro-
gram on the BD TotalysTM SlidePrep system, the unstained slides were stored in 95% ethanol.
This cytology slide preparation is referred to as the SurePathTM method. Following cytology
processing, the residual peritoneal fluid pellets were preserved at 2˚C for a few months until
use.
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Dual immunocytochemistry
Dual ICC was performed by using BenchMark XT Automated staining system (Ventana Medi-
cal Systems, Tucson, AZ) according to the manufacturer’s protocol. Cell Conditioning Solu-
tion (CC2; pH 6.0 citrate buffer; Ventana Medical Systems) was used for antigen retrieval.
Detection was performed using ultraView Universal 3,3’-diaminobenzidine (DAB) Detection
kits and ultraView Universal Alkaline Phosphatase (AP) Red Detection kits (Ventana Medical
Systems). For DAB staining, primary anti-PAX8 antibody (Cell Marque, 1:30) was applied and
incubated for 64 min.
Before the AP Red staining step, slides were incubated at 90˚C for 4 min. For AP Red stain-
ing, anti-CK7 antibody (DAKO, 1:100) was applied and incubated for 35 min, followed by the
AP Red multimer for 12 min. UltraView AP Red ISH Enhancer (Ventana Medical Systems)
was applied for 4 min at 37˚C. Slides were incubated for 8 min after simultaneous addition of
Fast Red A and Red Naphtol (Ventana Medical Systems). Slides were incubated with Fast Red
B (Ventana Medical Systems) for 8 min followed by hematoxylin and Bluing Reagent (Ventana
Medical Systems) counterstain at 37˚C.
Image analysis
A Mantra Quantitative Pathology Imaging System (Perkin-Elmer, Waltham, MA) was used
for acquiring multispectral images. Slides were imaged at 20× using Mantra Snap software
(Perkin-Elmer). inForm™ 2.2.1 software (Perkin-Elmer) and Spotfire QPS (Tibco; Hopkinton,
MA) were used for image analysis and quantification. MSI images were converted to RGB
images and embedded synthetic spectrums for hematoxylin, DAB, and Fast Red were used to
unmix the signals of these images. Bright field images were converted to fluorescent images for
convenient image analysis. Hematoxylin spectrums were used for cell segmentation. DAB and
Fast Red spectrums were used for detecting cytoplasmic areas. The optical densities of Fast
Red, DAB, and cell areas from each cell were quantified. Phenotyping using machine learning
was applied to divide cells into four types of cells: CK7-/PAX8-, CK7+/PAX8-, CK7+/PAX8-,
and CK7+/PAX8+.
Statistical analysis
The relationships between variables and primary origins were evaluated using chi-squared
tests. To compare the performance of the selected variables, receiver operating characteristic
(ROC) curves were constructed and the area under the curve (AUC) was compared. Compari-
sons were made using the Delong method for statistical significance of AUC.[11] Statistical
analyses were performed using SAS software (version 9.2, SAS Inc., Cary, NC). P-values were
adjusted using Bonferroni’s correction. P< 0.05 was considered statistically significant.
Results
Cytomorphological characteristics of each tumor cell cluster
Cells from malignant ascites cases were prepared using CytoRich Red as a liquid-based cytol-
ogy preservative. Overall, the morphology of these various malignant cells was well retained,
and several key cellular features were retained in these liquid-based cytology preparations. Fur-
thermore, obvious differences in various morpgology features could be detected among the
different primary tumor cells which had metastasized to the peritoneal cavity. These features
included clear morphology details of cytoplasm, nucleus, nucleolus, vacuoles and chromatin,
which are summarized in Table 1. Representative images of the different tumor cell clusters
are displayed in Fig 1.
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Optimization of dual immunocytochemistry
In addition to morphology features, we also analyzed the pattern of cell cluster as cytomor-
phology in liquid-based suspensions. Cluster analysis and analysis of CK7 and PAX8 expres-
sion on cells, isolated from peritoneal fluid, were used for the prediction of primary tumor
Table 1. A summary of the key morphological features identified in metastatic carcinoma present within ascites cases.
Primary site Cell Presentation Key Cytology Features
Stomach • Non-coherent cells; dispersed with no cluster • Irregular nucleus with bilobular features.
• Foamy cytoplasm with bubbles
Lung • Predominant, small-sized clusters and associated single cells • Central nucleus with prominent nucleoli.
• Lack of course chromatin
• Mucoid vacuoles
Pancreatobiliary tract • Small cell clusters, with uniformly round cells • Peripheral alignment of nuclei in cell clusters
• Prominent nucleoli
• Fine chromatin
• Mucoid vacuoles
Breast • Large cell clusters with three-dimensional structures
• Large atypical cells
• No single cells
• Course, clumped chromatin
Ovary • Large cell clusters; diffusely distributed
• Cells display consistent size and shape
• Prominent nucleoli
• Open chromatin
• Transparent to amphophilic cytoplasm
• Clear, protruding vacuoles
• Common borders in cell clusters
Colon • Three-dimensional clusters of variable cell size
• Clusters are scattered
• Oval to spindle shaped nucleus
• Prominent nucleoli
• Lacy, ragged cytoplasm
• Common border in cell clusters
https://doi.org/10.1371/journal.pone.0199715.t001
Fig 1. Representative cytology presentations of metastatic carcinoma. (A) stomach, (B) lung, (C) pancreatobiliary tract, (D) breast, (E) ovary and (F) colon cancer.
https://doi.org/10.1371/journal.pone.0199715.g001
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origin. We determined that performing the first nuclear staining with PAX8 ICC along with
DAB, followed by cytoplasmic/membranous staining with CK7 ICC along with and Fast Red
(Fig 2A and 2B), was more successful for recognizing dual signals than staining in the reverse
order (Fig 2C and 2D).
Cluster and immunocytochemistry patterns of peritoneal fluid
Each parameter showed significant statistics to the specific primary origin. In terms of three-
dimensional (3D) cluster, three tier categories were defined: ‘no 3D cluster’ was defined as no
discernable 3D cluster with diffusely dispersed smear; ‘small 3D cluster’ was defined as 3D
clusters composed of less than 10 cells at high magnification; and ‘large 3D cluster’ was defined
as 3D clusters composed of more than 10 cells at high magnification. Different dual staining
was easily recognized in scattered cells, but could be recognized in cell clusters as well (Fig 3).
Fig 2. Optimizing the order of dual immunocytochemistry for CK7 and PAX8. When the antibody that is used first affects the overall manifestation because the first
applied color becomes weak or even completely lost following staining with the second color. (A and B) Nuclear staining, using PAX8-specific antibody with DAB, was
performed first followed by cytoplasmic or membranous staining using CK7-specific antibody with Fast Red. (C and D) CK7 staining was performed first followed by
PAX8 staining. The initially applied CK7 red color becomes completely lost following DAB staining in the same case as in A and B.
https://doi.org/10.1371/journal.pone.0199715.g002
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Because background mesothelial cells are completely negative for the dual markers, any
stained cells raise suspicion of malignancy.
Three-dimensional cluster and immunocytochemistry patterns based on
the primary site
In malignant ascites from stomach cancer, 3D cluster showed an inverse correlation to proba-
bility of stomach origin. However, it was not significant (OR = 0.052 relative to no cluster;
P = 0.239) in univariate analysis. However, stomach cancer showed a tendency toward to be
associated with no 3D cluster in multivariate analysis (OR = 0.144; P = 0.097). When com-
bined with dual ICC, 3D cluster pattern became a significant factor associated with the pri-
mary origin (Fig 4A). Small 3D clusters were observed in some of stomach cancer and the
majority of pancreatobiliary tract cancers. In dual ICC, these cases showed CK7 expression
with PAX8 negativity (Fig 4B).
Fig 3. Typical immunocytochemistry patterns of cluster in peritoneal suspensions using LBC. (A) Two-dimensional sheet with a dual-negative (CK7-/PAX8-)
pattern represents mesothelial cells. (B) Three-dimensional large clusters with dual staining for nuclear PAX8 and cytoplasmic CK7. (C) Three-dimensional large
clusters with staining for cytoplasmic CK7, but no nuclear PAX8 staining. (D) Two-dimensional sheet with staining for CK7 indicates that the cells are not mesothelial
cells.
https://doi.org/10.1371/journal.pone.0199715.g003
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Large 3D cluster showed a significant correlation with ovarian cancer as the primary origin
(OR = 11.16; P< 0.0001) (Fig 4C and 4D). Besides ovarian cancer, colon and lung cancers
showed large 3D clusters dominant malignant ascites. However, ICC pattern of these two can-
cers differed and only lung cancer showed a significant correlation (OR = 16.67; P = 0.0069).
The morphological and ICC features of malignant peritoneal fluid samples are summarized in
Table 2.
Fig 4. Typical immunocytochemistry patterns based on primary origins. Three parameters, three-dimensional (3D) clusters and dual staining for
CK7 and PAX8, can identify the primary origin. Each panel represents different patterns of dual staining. (A) Stomach cancer: most cells are scattered
and show CK7+/PAX8- immunoprofile. (B) Gastrointestinal tract, including stomach and pancreatobiliary tract cancer: mostly small 3D cluster with
scattered cells are CK7+/PAX8-. (C and D) Female genital tract, including ovarian cancer: large 3D cluster with scattered cells are CK7+/PAX8+. There is
positive staining for nuclear PAX8-DAB in the cell with the large cytoplasm.
https://doi.org/10.1371/journal.pone.0199715.g004
Table 2. The summary of morphological and immunocytochemistry patterns.
Primary site 3D Cluster Cluster Type CK7 PAX8 Statistical Significance for Combined Result of Cluster Type and ICC Result
Stomach None
(single cells)
- + - AUC = 0.8699
Ovary Yes Large + + AUC = 0.9812
Pancreatobiliary Yes Small + - AUC = 0.8772
Breast/Lung/Colon Yes Large + - AUC = 0.882
 AUC is calculated for cases of which originated from lung.
https://doi.org/10.1371/journal.pone.0199715.t002
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Quantification of dual-stained cells in peritoneal fluid
Quantification of dual-stained cells via image analyzer was performed in malignant peritoneal
fluids with ovarian cancer. In ovarian cancer patients, quantification of dual-stained cells var-
ies from less than 30% to greater than 90% of the cell population (Figs 5 and 6). Dual-positive
fractions are variable because the cells suspended in ascites are heterogeneously mixed and
population ratios can differ between patients. Generally, the value is not accepted for quantifi-
cation and is discarded in cases of dual-positive staining of less than 5% of the total cell
population.
Receiver operating characteristic curve analysis
Multivariate analysis of factors associated with 33 stomach cancer patients revealed that small
cluster was significantly lower (OR = 0.144, P = 0.0097) than no cluster. When combined with
the three variables, AUC composed of no 3D cluster CK7+, and PAX8- was 0.8699 in ROC
curve analysis (Fig 7A). In multivariate analysis for 34 ovarian cancer patients, positive indica-
tions of all three parameters were significant for predicting ovarian cancer as the primary site.
PAX8 expression was absolutely required for predicting ovarian cancer (OR 999.99,
P< 0.001). The AUC was 0.9812 in ROC curve analysis (Fig 7B). Lung cancer samples showed
overlapping patterns of three parameters. However, large 3D cluster, CK7+, and PAX8- showed
a relatively high AUC of 0.882 (Fig 7C). Although colon and breast cancer samples had no
AUCs over 0.8 in any modality, the breast cancer samples had overlapping data with lung can-
cer. In multivariate analysis for 13 pancreatobiliary tract cancer patients, AUC composed of
small 3D clusters, CK7+, and PAX8- was 0.8772 in ROC curve analysis (Fig 7D).
Proposal of diagnostic decision tree
Classification and Regression Tree (CART) analysis was performed to predict the possibility of
primary site of peritoneal fluid samples. No 3D cluster and CK7+ could sufficiently predict the
possibility of stomach cancer as the primary tumor. PAX8 expression in peritoneal fluid sam-
ples was necessary for the prediction of ovarian cancer.
From these results, the combination of 3D cluster status and ICC with CK7 and PAX8 per-
mitted the ability to construct a diagnostic decision tree (Fig 8) to help identify the primary
cancer which metastasized into the peritoneal cavity. It permits a simple and strightfoward
method to help identify the primary tumor in these peritoneal fluid cytology specimens.
Discussion
LBC is better for proper interpretation than conventional cytology due to increased cellular
yields and clearer backgrounds.[1] When the third space effusion is applied to LBC, these mer-
its are accentuated and read times are decreased. Moreover, the greatest advantage of LBC is
its easy application for molecular ancillary studies, including ICC. However, there is no strong
supporting evidence for widely accepted biomarker panels for LBC in effusion fluids.[12]
In addition to determining whether cells within the effusion are benign or malignant, addi-
tional information as to the suspected origin based on evidence from immunopanels or molec-
ular panels will aid in the management and treatment of patients with unknown primary
dissemination. Currently, many studies have sought to determine the best marker for differen-
tiating between mesothelial cells and adenocarcinoma over the broad spectrum.[2] ICC using
LBC has been widely used in vaginal cytology with Ki-67 and p16,[4,5] and later adopted in
urine cytology for aiding in identification of high-grade urothelial carcinoma.[6] However, no
Diagnostic algorithm for the evaluation of malignant ascites
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supportive data on dual staining using other markers has been documented. Furthermore, cus-
tomized dual staining is difficult to optimize, which makes LBC less popular.
In the current study, we examined malignant ascites via peritoneal cytology. The five most
common primary sites within our cohort were 1) stomach, 2) ovary, 3) pancreatobiliary tract,
4) breast, and 5) lung cancers. We were able to differentiate primary site of peritoneal fluid
samples based on the combination of dual ICC using CK7 and PAX8, and 3D cluster patterns.
However, hurdles for dual ICC need to be overcome in both the technical and interpretational
aspects.[13] Specifically, the first applied color becomes weak or even completely lost following
application of the second color. Therefore, we optimized the technical aspect of dual staining
by first performing nuclear staining (PAX8 with DAB) and then performing cytoplasmic or
membranous staining (CK7 with Fast Red).
The expression of CK7, when combined with CK20 expression, can be used to determine
primary origin.[14] A previous study showed that for CK7+ tumors, the staining distribution
of CK7 was frequently diffuse (in> 50% of positive tumor cells) in primary ovarian, upper gas-
trointestinal tract (including pancreatobiliary tract), and endocervical tumors, whereas the
CK7 staining distribution was often focal (in< 50% of positive tumor cells) when present in
colorectal and appendix carcinomas.[15]
Our collection contained only 4 cases of cancer of the lower gastrointestinal tract. Although
CK7 expression in colon cancer is rare,[15,16] all of 4 cases showed relatively lower intensities
of CK7 staining. Thus, in our study, large 3D cluster and weak CK7 expression in SurePathTM
analysis raised the possibility of colorectal origin in malignant ascites. Although CK7 is a very
sensitive marker for screening malignant cells in third cavity fluids, which is essential for the
first panel, it can be expressed at variable levels in a broad-spectrum of cancers, including pan-
creatic, biliary tract, colon, breast, and lung, to evoke malignant ascites.
PAX8 is a nuclear marker which is commonly expressed in epithelial tumors of the thyroid
and parathyroid glands, kidney, thymus, and ovary.[10] In terms of malignant peritoneal
cytology, the presence of cells with ovary and kidney origins is possible. In our cohort, we col-
lected peritoneal cytology. However, PAX8 staining was non-existent in the case of metastatic
carcinoma from the kidney and could be ignored. Henceforth, PAX8 staining was very specific
to ovarian origin in malignant ascites, and can be considered the best choice for combining
with cytoplasmic staining.
The 3D clusters that were tightly composed of atypical cells appeared strikingly upward and
forward compared to the diffusely dispersed mesothelial cells in the background of the Sure-
PathTM technique. This is a unique merit not available with conventional cytopreparatory
smears or even with other LBC techniques. In the present study, cluster alone was not suffi-
cient for determination of primary origin. However, in some specific primary origins, cluster
pattern aided in the determination of the primary origin. Cells from ovarian and lung cancers
tend to form large clusters. Cells from pancreatic and biliary tract cancers tend to form small
aggregates, whereas stomach cancer seldom forms aggregates.
In ROC curve analysis to determine diagnostic biomarkers for the prediction of primary
site in malignant ascites, diagnostic algorithm using these three parameters showed high
AUCs over 0.8. The power to predict the primary site was best in ovarian cancer (AUC of
0.9812), which was specific to large 3D cluster/CK7+/PAX8+ for differentiating ovarian cancer
from gastrointestinal tract cancers. It is also plausible to differentiate stomach cancer from
Fig 5. Automatic digitalized interpretation of dual immunocytochemistry. In peritoneal aspirates from patients
with ovarian cancer, the suspended cells were very heterogeneous: a mixed population of mesothelial cells and
malignant tumor cells. Except for 265 mesothelial cells with dual negative staining (CK7-/PAX8-), all cells were
compatible with malignant cells. Approximately 30% of the cells had the typical dual staining (CK7+/PAX8+) pattern.
https://doi.org/10.1371/journal.pone.0199715.g005
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pancreatobiliary tract cancers, because both revealed quite different panels that seldom
overlapped.
Screening based on a blind eye is generally possible, but sometimes can be misleading
resulting in false negative or false positive diagnoses. The average difficulty of interpretation in
dual ICC was reported as 1.06, compared to 2.95 with the one-color method, suggesting that
the one-color method is approximately three times as difficult to interpret.[12] The difficulty
index increases in cases with few cells and cases with a predominance of isolated tumor cells.
For reproducible and accurate interpretations, automatic image analyzing tools are adopted.
[7] Cases with double-negative staining do not require an automatic analyzer, while other
cases require digitalized fractionation of each cell type. Using the image analyzer, most of the
ovarian and stomach cancers were clearly shown to be mainly dual positive and dual negative,
respectively. However, other types of cancers, such as pancreatic, lung, and breast, showed
Fig 6. Automatic digitalized interpretation of dual immunocytochemistry. In most cases of ovarian cancer, cells
with the typical dual staining (CK7+/PAX8+) pattern represented over 90% of the cell population.
https://doi.org/10.1371/journal.pone.0199715.g006
Fig 7. Estimated ROC curve analysis using the three parameters to predict primary origin. (A) In stomach cancer, AUC was 0.8699. (B) In ovarian cancer, the AUC
was 0.9812. (C) In lung cancer, the AUC was 0.882. (D) In pancreatobiliary tract cancer, the AUC was 0.8772.
https://doi.org/10.1371/journal.pone.0199715.g007
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wide ranges of dual staining. With principle of omission of values less than 5%, major fractions
were accepted as true signals.
The current reporting system is merely negative or positive for malignancy. However, this
upgraded technique can provide the following additional outcome of “Positive for malignancy
likely originating from the stomach (or ovary or pancreatobiliary tract). Clinical survey for stom-
ach (or ovary or pancreatobiliary tract) evaluation is suggested.”. Therefore, we suggest the diag-
nostic algorithm as follows: 1) When no or only small 3D clusters are visible in LBC with only
CK7 positivity, we recommend “Positive for malignancy likely originating from the stomach.
Clinical survey for stomach evaluation is suggested.”. 2) When many large 3D clusters are visible
in LBC with CK7 and PAX8 positivity, we recommend “Positive for malignancy likely originat-
ing from the uterus or ovary. Clinical survey for gynecologic evaluation is suggested.”. 3) When
many small 3D clusters are visible in LBC with only CK7 positivity, we recommend “Positive
for malignancy likely originating from the pancreatobiliary tract. Clinical survey is suggested.”. 4)
When many large 3D clusters are visible in LBC with only CK7 positivity, we recommend
“Positive for malignancy likely originating from breast, lung, or colon. Clinical survey is sug-
gested.”. When additional details as to the primary origin are requested, a second panel includ-
ing TTF-1, CDX-2, and mammoglobin can be performed to further narrow the broad
category.
Fig 8. Diagnostic decision tree for peritoneal fluid cytology utilizing cellular cluster and immunocytochemistry patterns to identify primary cancers which have
metastatized to peritoneal fluids.
https://doi.org/10.1371/journal.pone.0199715.g008
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Conclusions
LBC (CytoRich using the SurePathTM method) involving dual ICC with CK7 and PAX8 stain-
ing and 3D cluster patterns as a surrogate biomarker can provide information as to the pri-
mary origin in patients with malignant ascites of unknown primary origin.
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